Department of the Army June 29, 2011 – Federal Register Recent Federal Regulation Documents
Results 1 - 2 of 2
Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning the Guanidylimidazole and Guanidylimidazoline Derivatives as Antimalarial Agents, Synthesis of and Methods of Use Thereof
Announcement is made of the availability for licensing of the invention set forth in U.S. Provisional Patent Application Serial No. 61/517,858, entitled ``Guanidylimidazole and Guanidylimidazoline Derivatives as Antimalarial Agents, Synthesis of and Methods of Use Thereof,'' filed on April 26, 2011. The United States Government, as represented by the Secretary of the Army, has rights to this invention.
Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning the 2-Guanidino-4-oxo-Imidazoline Derivatives as Antimalarial Agents, Synthesis of and Methods of Use Thereof
Announcement is made of the availability for licensing of the invention set forth in U.S. Provisional Patent Application Serial No. 61/518,800, entitled ``2-Guanidino-4-oxo-Imidazoline Derivatives as Antimalarial Agents, Synthesis and Methods of Use Thereof,'' filed on April 26, 2011. The United States Government, as represented by the Secretary of the Army, has rights to this invention.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.